Revance Therapeutics Inc. sell nvestor
Start price
11.05.24
/
50%
€3.12
Target price
11.05.25
€1.00
Performance (%)
-8.33%
End price
19.05.24
€2.86
Summary
This prediction ended on 19.05.24 with a price of €2.86. With a performance of -8.33%, the SELL prediction for Revance Therapeutics Inc. by nvestor was down slightly. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by nvestor for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Sell mit Kursziel 1,0
In the thread Trading Revance Therapeutics Inc.
Sell beendet
Stopped prediction by nvestor for Revance Therapeutics Inc.
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.64
09.11.24
09.11.24
€1.00
09.11.25
09.11.25
-1.10%
23.11.24
23.11.24

